“Bipartisan Praise”: Whitmer Leads Bipartisan Effort to Lower Michigan’s Insulin Costs
This week, Gov. Gretchen Whitmer signed an executive directive seeking to lower insulin costs. The directive, which has gained bipartisan support, would allow the state of Michigan to develop its own manufacturing capabilities and lower costs for the life-saving medicine.
The Michigan Advance noted that Gov. Whitmer received “bipartisan praise,” while Republican state Sen. Curt Vanderwall voiced his support for Gov. Whitmer’s action, saying, “With so many Michiganders struggling to manage their diabetes, access to readily available and affordable insulin is critical. All insulin users, including those with both public or private insurance plans, should have that opportunity and get the insulin they need.”
In September, the Whitmer campaign announced Republicans for Whitmer, a group of over 150 Michigan Republicans supporting her re-election and led by a leadership council of prominent business leaders, former lawmakers, and staff of former Republican governors John Engler and Rick Snyder.
“Gov. Gretchen Whitmer’s push to lower Michigan’s insulin cost is just one example of how she’ll work with anyone to make life more affordable for working families,” said DGA Deputy Communications Director Sam Newton. “The choice is clear — Gov. Whitmer is the only candidate for governor willing to cross party lines to bring real results to Michigan’s families.”